Skip Navigation
  • The MHH
  • International office
  • Emergency numbers
  • Patients & Visitors
  • Facilities & Departments
    • Facilities & Departments
    • MHH Clinical departments
    • MHH-Institutes
    • Clinical departments and institutes sorted by center
    • Interdisciplinary centers
    • Central facilities
  • Research
    • Research
    • Research foci
      • Research foci
      • COVID-19
    • Core Research Units
      • Core Research Units
      • MeDIC
      • Hannover Unified Biobank (HUB)
      • Lasermikroskopie
      • Research Core Unit Electron Microscopy
    • Academic Career Development
    • Advisory Services
      • Advisory Services
      • DFG
    • Research Infrastructure
    • Dean of Research
    • Good Scientific Practice
      • Good Scientific Practice
      • Commission for Good Scientific Practice
      • Ombuds Office and Ombudsperson
    • Transparency in Research
    • Research Funding, Knowledge & Technology Transfer
      • Research Funding, Knowledge & Technology Transfer
      • Partners & Networks
      • For life scientists
      • For partners & investors
      • For startups and founders
  • Studying at MHH
    • Studying at MHH
    • All degree programs
    • Registrar's Office
      • Registrar's Office
      • Prospective students
      • Students
      • Dates & deadlines
      • Contact
  • Careers
Welcome to the MHH
Searched for contact. Found 531 results in 3 Millisekunden.

Filter by:

  • All content
  • Common content
  • Ambulances
  • News
  • «
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • »
News

Neurology study: Researchers look for ways of early Parkinson's therapy

Relevance: 58%
 

explains Dr. Klietz. Participants wanted For more information about the study, interested parties can contact RBD@mh-hannover.de . Author: Kirsten Pötzke

News

MHH: 1.5 million euros for rapid therapies against viral diseases

Relevance: 58%
 

year, the team can apply for the third funding round. SERVICE: For further information , please contact Professor Dr. Dr. Axel Schambach, schambach.axel@mh-hannover.de , telephone (0511) 532-5170.

News

More safety for medicines

Relevance: 58%
 

information, please visit the homepage www.RESIST-cluster.de. SERVICE: For further information, please contact Professor Dr Nico Lachmann, Lachmann.Nico@mh-hannover.de , telephone (0511) 532-5366.

News

The MHH mourns the death of Professor Hans Borst

Relevance: 58%
 

academic self-administration were of great concern to him. Even after his retirement, he kept in close contact with "his" hospital and was often a guest there. He remembered the beginnings in Hanover with particular

News

Septic shock: MHH team researches new treatment strategy

Relevance: 58%
 

euros over 36 months, will start at the beginning of 2023. SERVICE: For further information , please contact Professor Dr Sascha David, david.sascha@mh-hannover.de , and Privatdozent Dr Klaus Stahl, stahl.

News

Rapid diagnosis instead of a long odyssey

Relevance: 58%
 

in standard care to all seriously ill children in the future." SERVICE: For more information , contact Dr. Bernd Auber, auber.bernd@mh-hannover.de , phone (0511) 532-8719.

News

New gene taxis to combat liver disease

Relevance: 58%
 

waiting for the MLIV.K and MLIV.A gene taxis in the future. SERVICE: For further information , please contact Professor Dr Hildegard Büning, buening.hildegard@mh-hannover.de , telephone (0511) 532-5106. The

News

Thanks to umbilical cord stem cells: First successful treatment of severe pulmonary hypertension

Relevance: 58%
 

therapy-resistant pulmonary arterial hypertension (PAH). SERVICE For further information , please contact Professor Dr. Georg Hansmann, telephone (0511) 532-9594, hansmann.georg@mh-hannover.de . The original

News

MHH researcher wants to stop harmful effect of chemotherapy on heart muscle

Relevance: 58%
 

injury, for which there is currently no specific treatment. SERVICE: For further information , please contact Professor Dr. Dr. Thomas Thum, thum.thomas@mh-hannover.de , telephone (0511) 532-9174.

News

Help for the weakened heart

Relevance: 58%
 

for the use of MYGDF as a new drug for heart failure. SERVICE: For further information , please contact Professor Dr. Kai Wollert, wollert.kai@mh-hannover.de , telephone (0511) 532-4055. The original paper

  • «
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • »
Imprint Intranet Contact Privacy Accessibility
The MHH Hospital is a maximum care hospital with a nationwide catchment area. The university teaches medicine, dentistry, biochemistry, biomedicine, midwifery and health sciences. The main research areas are Transplantation and Stem Cell Research / Regenerative Medicine, Infection and Immunology Research, Biomedical Engineering and Implant Research.

   

Information about

Blood donation service MHH-Alumni e.V.

Follow us on

Facebook Instagram YouTube Xing LinkedIn
© 2019 - 2025 Medizinische Hochschule Hannover
Nach oben scrollen